General Updates

June 24, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex Mumbai - 400 001 Bandra (E) Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir, In continuation to our disclosure dated May 22, 2026 and pursuant to Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 we hereby submit that an Order has been received from the Income tax department in the matter of Jubilant Generics Limited (“JGL”) (a wholly owned step down Indian subsidiary) of the Company. In this regard, we wish to inform that JGL had preferred a rectification application in respect of income assessed by the Income Tax Department for the Assessment Year 2023-24. Pursuant to such rectification tax adjustments have been reduced from Rs. 107.89 crs to Rs. 42.41 crs. The appeal on merit ground is being pursued before CIT(A) separately. The information in the relevant format is enclosed as Annexure A. Date and time of receipt of order is June 23, 2026, 10:17 PM (IST). The above-mentioned document is being simultaneously posted on the Company's website at www.jubilantpharmova.com. We request you to take this on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Annexure A The details of any change in the In the case of litigation against key In the event of settlement of the status and / or any development management personnel or its promoter proceedings, details of such in relation to such proceedings or ultimate person in control, regularly settlement including - terms of the provide details of any change in the settlement, compensation/penalty status and / or any development in paid (if any) and impact of such relation to such proceedings settlement on the financial position of the listed entity. Jubilant Generics limited has Not Applicable JGL has got the relief from the relevant received a Rectification Order Transfer Pricing Officer thereby dated June 23, 2026, for AY 2023- restoring the tax losses of Rs. 65.48 crs. 24 reducing total tax adjustments made from Rs. 107.89 crs to Rs. 42.41 crs.